研究・開発 Jul 04, 2023 企業の研究開発マネージメントとスイス スイスでは産学が現実に即した協力体制を取っており、それが製品の市場化までの時間を早めるのに大いに貢献しています。応用科学に重点を置くスイスのユニークな特徴が、貴社にどのようにお役に立てるかをご覧ください。
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News Nov 01, 2023 Palto Therapeutics receives 150,000 Swiss francs from Venture Kick Palto Therapeutics has won the third stage of the Venture Kick promotional funding program. As such, the company now stands to benefit from 150,0...
News Oct 31, 2023 Debiopharm invests CHF 30 million in Valais amidst workforce surge Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150...
Aktuell Aug 15, 2022 BioFi AG gründet sich in Basel neu BioFi hat seinen Firmensitz in Basel genommen. Das Unternehmen ist aus der 2000 im US-Bundesstaat Idaho gegründeten Firma Crowley Davis Research ...
News Oct 18, 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News Oct 17, 2023 Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund Vaud-based start-ups Voltiris, Limula, and Parithera gain momentum in their innovative ventures as they secure vital funding and support from Bio...
Réseau Associations professionnelles et organismes de soutien en Suisse Associations professionnelles suisses à orientation internationale (sélection).
Aktuell Aug 23, 2023 Forty51 Ventures finanziert Gründung von Mysthera Therapeutics Die Mysthera Therapeutics AG ist in Basel gegründet worden. Das Startkapital in Höhe von 3,5 Millionen Dollar stammt von der Basler Risikokapital...
News Oct 10, 2023 HES-SO Valais-Wallis and Debiopharm partner up to battle cancer HES-SO Valais-Wallis and Debiopharm have entered a partnership to advance targeted cancer therapy research with novel antibody conjugates.
News Oct 23, 2020 JSR Life Sciences to expand KBI Biopharma and Selexis’ biologics manufacturing capabilities in Geneva A newly expanded, state-of-the-art facility will house both biologics manufacturer KBI Biopharma and cell line developer Selexis. Together, the t...
News Oct 11, 2023 Lonza further extends its ADC manufacturing capabilities in Visp Lonza amplifies ADC production via a robust extension in bioconjugation capacity at its Ibex Dedicate Biopark in Visp, which set to generate 180 ...
News Sep 29, 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News Jan 30, 2018 Zurich tops quality of living ranking Zurich is once again the second best city in the world for overall quality of life, according to the 2017 Mercer Quality of Living survey.
Aktuell Jul 07, 2023 Roche und ETH bilden die nächste Generation aus Das Basler Life Sciences-Unternehmen Roche und die Eidgenössische Technische Hochschule Zürich (ETH) bilden gemeinsam Biomedizinerinnen und Biome...
News Aug 29, 2017 Zurich, Geneva and Basel among top 10 cities with highest quality of living worldwide Swiss cities continue to receive top marks when it comes to expatriate quality of living. According to the new quality-of-living rankings by Merc...